SPOTO, BELINDA GILDA
 Distribuzione geografica
Continente #
AS - Asia 1.927
NA - Nord America 1.203
EU - Europa 493
SA - Sud America 381
Continente sconosciuto - Info sul continente non disponibili 133
AF - Africa 40
OC - Oceania 5
Totale 4.182
Nazione #
US - Stati Uniti d'America 1.116
SG - Singapore 837
CN - Cina 408
BR - Brasile 288
VN - Vietnam 213
HK - Hong Kong 198
IT - Italia 191
FR - Francia 121
KR - Corea 69
BD - Bangladesh 54
CA - Canada 33
IN - India 33
AR - Argentina 31
JP - Giappone 30
GB - Regno Unito 29
NL - Olanda 28
DE - Germania 25
CO - Colombia 19
MX - Messico 17
EC - Ecuador 16
FI - Finlandia 16
ID - Indonesia 14
UA - Ucraina 13
IQ - Iraq 11
SA - Arabia Saudita 11
RU - Federazione Russa 10
CR - Costa Rica 9
IL - Israele 9
UY - Uruguay 9
JM - Giamaica 8
PL - Polonia 8
AT - Austria 7
EG - Egitto 7
ES - Italia 7
IE - Irlanda 7
MA - Marocco 7
TT - Trinidad e Tobago 7
VE - Venezuela 7
SE - Svezia 6
TR - Turchia 6
AU - Australia 5
HR - Croazia 5
PK - Pakistan 5
ZA - Sudafrica 5
AL - Albania 4
HN - Honduras 4
JO - Giordania 4
MY - Malesia 4
NP - Nepal 4
OM - Oman 4
PH - Filippine 4
TN - Tunisia 4
CL - Cile 3
DZ - Algeria 3
GR - Grecia 3
KE - Kenya 3
NI - Nicaragua 3
PE - Perù 3
PR - Porto Rico 3
PT - Portogallo 3
BO - Bolivia 2
CI - Costa d'Avorio 2
HU - Ungheria 2
KZ - Kazakistan 2
LT - Lituania 2
NG - Nigeria 2
PY - Paraguay 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BS - Bahamas 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GF - Guiana Francese 1
KW - Kuwait 1
MM - Myanmar 1
MR - Mauritania 1
MT - Malta 1
NO - Norvegia 1
RS - Serbia 1
RW - Ruanda 1
SI - Slovenia 1
SN - Senegal 1
SO - Somalia 1
TG - Togo 1
TW - Taiwan 1
ZW - Zimbabwe 1
Totale 4.049
Città #
Singapore 512
Santa Clara 266
Hong Kong 197
Hefei 116
Ashburn 107
Lauterbourg 101
Beijing 96
San Jose 94
Ho Chi Minh City 74
Los Angeles 68
Seoul 67
Hanoi 49
São Paulo 28
New York 27
Dallas 23
Tokyo 19
Chicago 14
Frankfurt am Main 13
Helsinki 12
Buffalo 11
Da Nang 11
Milan 11
Philadelphia 10
Rio de Janeiro 10
Amsterdam 9
Council Bluffs 9
Belo Horizonte 8
Brasília 8
Düsseldorf 8
Haiphong 8
Minamishinagawa 8
Warsaw 8
Catania 7
Chennai 7
Orem 7
The Bronx 7
Bari 6
Cairo 6
Dublin 6
Guarulhos 6
Montevideo 6
Rome 6
San José 6
Stockholm 6
Thái Bình 6
Biên Hòa 5
Denver 5
Guayaquil 5
Houston 5
Hải Dương 5
Miami 5
Naples 5
Osasco 5
Phoenix 5
Quito 5
Sorocaba 5
Zagreb 5
Amman 4
Baghdad 4
Bengaluru 4
Birmingham 4
Boston 4
Buenos Aires 4
Curitiba 4
Florence 4
Jeddah 4
Kingston 4
Lappeenranta 4
Las Vegas 4
Lima 4
Louisville 4
Manchester 4
Paris 4
Paternò 4
Riyadh 4
Toronto 4
Turin 4
Vienna 4
Washington 4
Atlanta 3
Austin 3
Belém 3
Bogotá 3
Brooklyn 3
Bắc Giang 3
Can Tho 3
Catalão 3
Cincinnati 3
City of London 3
Columbus 3
Formosa 3
Ha Long 3
Hyderabad 3
Jacksonville 3
Jakarta 3
Johannesburg 3
Lancaster 3
Lanham 3
London 3
Medellín 3
Totale 2.295
Nome #
Role of Gut Microbiota in Overweight Susceptibility in an Adult Population in Italy 130
8-hydroxy-2′-deoxyguanosine, a biomarker of oxidative DNA injury, in diabetic kidney disease 129
Neuropeptide y gene polymorphisms and chronic kidney disease progression 82
Role of kidney function on Nrf2 mRNA levels in type 2 diabetes 80
Selenoprotein P-1 (SEPP1) as an Early Biomarker of Acute Kidney Injury in Patients Undergoing Cardiopulmonary Bypass 76
Sample Size Calculation in Genetic Association Studies: A Practical Approach 74
Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance 71
A polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based study 69
ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies 68
Inflammation biomarkers and inflammatory genes expression in metabolically healthy obese patients 68
Serum gamma-glutamyltransferase, oxidized LDL and mortality in the elderly 67
Selenoprotein P-1 (SEPP1) as an Early Biomarker of Myocardial Injury in Patients Undergoing Cardiopulmonary Bypass 65
Elementi di fisiologia e biologia molecolare del trasporto tubulare del sodio 64
A Genetic Marker of Uric Acid Level, Carotid Atherosclerosis, and Arterial Stiffness: A Family-Based Study 63
Perioperative Marinobufagenin (MBG) Measurement May Improve Acute Kidney Injury Risk Assessment in Patients Undergoing Major Cardiac Surgery: A Proof-of-Concept Study 63
Hyperhomocysteinemia and arteriovenous fistula thrombosis in hemodialysis patients 62
The sirtuinl gene associates with left ventricular myocardial hypertrophy and remodeling in two chronic kidney disease cohorts: a longitudinal study 60
Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges 58
Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study 56
Tissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failure 55
A POLYMORPHISM IN THE SIRT-1 GENE ASSOCIATES WITH CONCENTRIC REMODELLING OF THE LEFT VENTRICLE AND PREDICTS THE LONGITUDINAL EVOLUTION OF THIS ALTERATION BOTH IN STAGE G1-5 CKD PATIENTS AND IN DIALYSIS PATIENTS 55
Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity 54
Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD 54
A polymorphismin a major antioxidant gene (Kelch-like ECH-associated protein1) predicts incident cardiovascular events in chronic kidney disease patients: an exploratory study 53
Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression 51
A Genetic Biomarker of Oxidative Stress, the Paraoxonase-1 Q192R Gene Variant, Associates with Cardiomyopathy in CKD: A Longitudinal Study 50
Insulin resistance in chronic kidney disease: a systematic review 48
Neuropeptide Y receptor Y2 gene polymorphism interacts with plasma neuropeptide Y levels in predicting left ventricular hypertrophy in dialysis patients 46
Atherosclerosis and the Glu298Asp polymorphism of the eNOS gene in white patients with end stage renal disease. 46
Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients. 46
Mendelian randomization: a new approach to studying epidemiology in ESRD 46
Resistin and all-cause and cardiovascular mortality: Effect modification by adiponectin in end-stage kidney disease patients 46
eNOS and Caveolin-1 Gene Polymorphisms Interaction and Intima Media Thickness: A Proof of Concept Study in ESRD Patients. 44
Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance. 43
The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: Evidence for interaction with obesity in diabetic patients 43
Circulating adiponectin modifies the FGF23 response to vitamin D receptor activation: a post hoc analysis of a double-blind, randomized clinical trial 43
The rs17384213 polymorphism in the DDAH1 gene is a marker of chronic allograft dysfunction. 41
Polymorphismes des gènes du système rènine et progression de l'atteinte rènale : une revue critique 41
Association of a polymorphism in a gene encoding a urate transporter with ckd progression 40
I polimorfismi del gene ENPP1 si associano ad ipertrofia ventricolare sinistra ed alla funzione sistolica nei pazienti in dialisi. 40
Joint effect of insulin signaling genes on all-cause mortality 39
An additive effect of endothelial nitric oxide synthase gene polymorphism contributes to the severity of atherosclerosis in patients on dialysis. 36
Il polimorfismo T585C del gene del recettore Y2 del Neuropeptide Y (NPY2R) interagisce con i livelli plasmatici di NPY nel predire l'ipertrofia ventricolare sinistra (IVS) nei pazienti in dialisi. 36
The E-selectin gene polymorphism and carotid atherosclerosis in end-stage renal disease. 35
La randomizzazione Mendaliana come "variabile strumentale" negli studi osservazionali. 35
The fat-mass and obesity-associated gene (FTO) predicts mortality in chronic kidney disease of various severity 35
Oxidized LDL, Gamma-Glutamyltransferase and Adverse Outcomes in Older Adults 35
Il sistema metabolico che regola l'ADMA è presente negli adipociti umani ed è iperespresso nell'insufficienza renale. 34
ENPP1 Gene Polymorphisms are associated with left ventricular (LV) mass and systolic function in end stage renal disease (ESRD) patients. 34
Vitamin D receptor activation by paricalcitol and insulin resistance in CKD 34
Association between resistin levels and all-cause and cardiovascular mortality: A new study and a systematic review and meta-analysis 33
The deletion polymorphism of the angiotensin-converting-enzyme is associated with nephroangiosclerosis 32
Endothelial nitric oxide sinthase (eNOS) polymorphism interacts with asimmetric dimethyl arginine (ADMA) in determining all cause and cardiovascular mortality in patients with ESRD. 32
Functional correlates and gene expression in fat cells of visfatin/pre-b cell enhancing factor in ckd patients. 32
Resistin and all-cause and cardiovascular mortality: effect modification by adiponectin in end-stage kidney disease patients. 32
The enzymatic machinery for ADMA synthesis and degradation is fully expressed in human adipocytes 31
Does asymmetric dimethylarginine play a role in depression in chronic kidney disease patients? 31
Interazione tra le varianti geniche della Caveolina-1 e dell'ossido nitrico sintetasi nel determinare la severità dell'aterosclerosi carotidea nei pazienti in dialisi. 31
Insulin resistance and left ventricular hypertrophy in end-stage renal disease: association between the ENPP1 gene and left ventricular concentric remodelling. 31
Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review 31
Infiammazione sistemica ed espressione genica nel tessuto adiposo sottocutaneo delle citochine infiammatorie nei pazienti con insufficienza renale cronica. 30
Interazioni tra le varianti geniche dell'ossido nitrico sintetasi e l'ADMA plasmatica nella mortalità cardiovascolare nei pazienti in dialisi 30
The GLU298ASP variant of nitric oxide synthase interacts with asymmetric dimethyl arginine in determining cardiovascular mortality in patients with end-stage renal disease 30
Il sistema metabolico che regola l'ADMA è presente negli adipociti umani ed è iperespresso nell'insufficienza renale. 29
Polymorphisms in the genes of the renin system and progression of renal disease: a critical review 29
Tissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failure. 29
Urotension II and renal disease: protective or causal role? 29
Proteinuria: a risk factor not to be overlooked in SLE 28
Le componenti funzionali che controllano la sintesi e la degradazione della dimetil-arginina asimmetrica (ADMA) sono espresse nel tessuto adiposo. 28
ACE-genotype and ACE-inhibitors-induced renoprotection in chronic proteinuric nephrophaties 28
Genetica dell'iperaldosteronismo primitivo. 28
Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance 28
Valore prognostico della variante Glu298Asp dell'ossido nitrico sintetasi (eNOS) e dell'interazione eNOS-Arginina Asimmetrica (ADMA) nei pazienti in dialisi. 27
Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review (vol 30, pg 6, 2015) 27
Insulin Sensitivity, Systemic Inflammation and Adipose Tissue Gene Expression of Inflammatory Cytokines in Chronic Kidney Disease (CKD) and in Obese Patients. 27
I polimorfismi del gene che regola la sintetasi dell'ossido nitrico contribuiscono all'aterosclerosi nei pazienti in dialisi. 27
Asymmetric Dimethylarginine (ADMA) Enzymatic Machinery and Adipokines Gene Expression in the Adipose Tissue in Stage 3-5 CKD patients. 27
Insulin Sensitivity, Systemic Inflammation and Adipose Tissue Gene Expression of Inflammatory Cytokines in Chronic Kidney Disease (CKD) and in Obese Patients. 26
The interaction of a common variant of the eNOS gene with asymmetric dimethylarginine (ADMA) in carotid atherosclerosis in end stage renal disease (ESRD). 26
Il polimorfismo T585C del gene del ricettore Y2 del neuropeptide Y (NPY2R) interagisce con i livelli plasmatici di NPY nel determinismo dell'ipertrofia ventricolare sinistra (IVS) nei pazienti in dialisi. 26
The full ADMA machinery is expressed in human adipocytes: differential regulation in healthy and uremic man. 26
ADMA machinery is expressed in adipocytes in humans and it is differentially regulated in CKD and ESRD patients 26
Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcome stage renal disease patients. 25
The full ADMA machinery is expressed in human adipocytes: differential regulation in healthy and uremic man. 25
Systemic and adipose tissue inflammation in chronic kidney disease (CKD) patients. 24
Methylarginine enzymatic machinery and Leptin in adipose tissue in CKD patients. 24
Effect of simvastatin on plasma asymmetric dimethylarginine concentration in patients with chronic kidney disease. 24
Polymorphisms in the genes of the renin system and progression of renal disease: a critical review. 23
Spleen IL-10, a key player in obesity-driven renal risk 23
eNOS gene polymorphisms contribute to the severity of carotid atherosclerosis in dialysis patients. 23
Functional correlates and gene expression in fat cells of visfatin/pre-b cell enhancing factor in CKD patients. 23
The deletion polymorphism of the angiotensin-converting enzyme is associated with nephroangiosclerosis. 23
Il polimorfismo C242T del gene per la subunità p22 dell'NADPH e il rischio cardiovascolare nei pazienti in dialisi. 22
L'allele T della variante GLU298ASP dell'ossido nitrico sintetasi (eNOS) è un fattore predittivo indipendente di aterosclerosi carotidea nei pazienti in dialisi. 22
MicroRNA: una piccola grande molecola. 22
Polymorphisms within the endpthelial nitric oxide synthase gene interact with plasma ADMA in predicting cardiovascular mortality in ESRD patients 22
Methylarginine enzymatic machinery and Leptin in adipose tissue in CKD patients. 21
Estimated Glomerular Filtration Rate, All-Cause Mortality and Cardiovascular Diseases Incidence in a Low Risk Population: The MATISS Study 21
Adpose tissue and renal disease. 21
Il polimorfismo L554F del gene della E-selettina è associato con l'ispessimento intimale, stenosi e rimodellamento vascolare in pazienti in dialisi. 20
Totale 4.078
Categoria #
all - tutte 14.968
article - articoli 11.163
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 243
Totale 26.374


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202461 0 0 0 0 0 0 0 0 40 0 21 0
2024/20251.438 12 5 127 104 288 17 29 84 75 53 358 286
2025/20262.245 107 223 196 291 406 111 375 144 100 137 104 51
2026/2027438 184 109 145 0 0 0 0 0 0 0 0 0
Totale 4.182